Our Team
Scientists and builders who originate conviction.
MEET THE TEAM
BARBARA HERBST
Deputy Chief Compliance Officer
MARY PAT JOYCE
Data Analytics Manager
JAKE SIMSON, PhD
Partner
PIETER BOELHOUWER
Managing Director + Strategy and Operations
AMBER BROWN
Senior Executive Assistant to the Co-founders
SHAN SHAN WANG, PhD
Associate
BARBARA HERBST
Deputy Chief Compliance Officer
Barbara Herbst is the Deputy Chief Compliance Officer at RA Capital Management. She is involved with the firm’s back office and operations, including finance, audit, compliance, partner relationships, and business continuity and policies. Barbara holds a BS in Business Administration with a concentration in Finance from Boston University and has 11 years of experience in operations, compliance, and trading.
MARY PAT JOYCE
Data Analytics Manager
<p>Mary Pat Joyce is a Data Analytics Manager at RA Capital Management. Mary Pat’s primary responsibilities at RA Capital are to coordinate various projects across the company and oversee their initiation, planning, and execution. Mary Pat is a PMI-certified Project Management Professional (PMP). She holds a BA in Chemistry from Holy Cross, where she studied biodiesel fuel analysis, and a Masters of Science in Analytics from Villanova University.</p>
JAKE SIMSON, PhD
Partner
<p>Jake Simson is a Partner at RA Capital Management. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. Previously, Jake covered solid tumor oncology landscapes. Jake holds a BS in Materials Science and Engineering from MIT and a PhD in Biomedical Engineering from Johns Hopkins University. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels.</p>
PIETER BOELHOUWER
Managing Director
Pieter Boelhouwer is a Managing Director of Strategy and Operations at RA Capital Management. Pieter’s primary responsibility at RA Capital is to lead major strategic initiatives and drive operational excellence across the firm. Pieter holds a BA from Trinity College and a JD from Yale Law School. Pieter previously worked as a consultant with McKinsey & Company, where he managed a variety of healthcare engagements, including pharmaceutical mergers, biotech product launch plans, OTC product rationalization, and hospital acquisitions. He held senior management positions at two successful start-up companies that were acquired and he has over 14 years of experience investing in the global healthcare sector, both as a Partner and Managing Director at Matrix Capital Management and as a General Partner and Managing Director at Ayer Capital Management, a healthcare-focused hedge fund. He also gained extensive legislative and public policy experience early in his career as a Legislative Aide to former United States Senator David Boren, and as a Domestic Policy Advisor to former Vice President Al Gore. Pieter has been recognized as one of the outstanding leaders in the U.S. through his selection as a White House Fellow, and he currently serves on the Board of Directors of the White House Fellows Foundation.
AMBER BROWN
Senior Executive Assistant to the Co-founders
<p>Amber is Senior Executive Assistant to the Co-founders at RA Capital Management. Her primary responsibilities are to coordinate calendars, events, and company meetings. She previously held Executive Assistant and Senior Executive Assistant roles at Genuity Science, Charles River Laboratories, and Gloucester Graphics, Inc. Amber has a dual BA concentration in International Business & Modern Languages from Northeastern University and studied abroad at American University of Paris.</p>
SHAN SHAN WANG, PhD
Associate
Shan Shan is an Associate within the TechAtlas division of RA Capital Management. Shan Shan’s primary responsibility is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Shan Shan holds a PhD in Neuroscience from Harvard University and a BS in Brain and Cognitive Sciences from MIT.